Meyers is the senior vice president of the North America Commercial Organization at Gilead Sciences, responsible for the commercialization of all Gilead products in the U.S. & Canada, and the functions of Sales & Marketing, Managed Markets/Pricing/Contracting, Commercial Operations and Distribution. He joined Gilead in 1996 as one of the founding members of the commercial organization, and has played a leading role in the growth of the company to its current position as one of the top companies in the biopharmaceutical industry. In addition to his North American responsibilities, Meyers has been responsible for the global governance of the Gilead-BMS Joint Venture that produced ATRIPLA, and the Gilead-J&J partnership that produced Complera, as well as global marketing responsibility during the initial build-out of Gilead operations beyond the U.S. Prior to joining Gilead, Meyers served in positions of increasing responsibility with Astra and Zeneca in New York City and Boston. Meyers received his bachelor’s degree in economics from Boston College, and is a 27-year veteran of the biopharmaceutical industry.